Sio Gene Therapies (SIOX) Peer Comparison

$0.48

$0.01 (1.70%)

As on 07-Feb-2024 15:59EDT

Market cap

$35 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Market cap ($ Mln)	35	380
Revenue ($ Mln)	--	22
Net Profit ($ Mln)	-28.17	69.86
Net Margin (%)	--	319.87
RoE (%)	-58.13	76.80
Price to Earnings	--	--
Price-To-Book	0.78	4.74

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Operating Revenue	0.00	6.99
Cost of Revenue	0.80	2.43
Gross Profit	-0.80	4.55
Operating Expenses	71.56	36.15
Operating Profit (EBIT)	-72.27	-31.59
Other Income	--	--
Profit before Tax	-71.63	-9.01
Provision for Tax	0.26	-1.13
Profit after Tax (Net Income)	-71.89	-7.88
Minority Interest	--	--
Consolidated Profit	-71.89	-150.66

Liabilities ($ Mln)

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Shareholder's Funds	60.35	98.26
Minority Interest	--	--
Non-Current Liabilities	1.73	60.08
Current Liabilities	13.00	60.57
Total Liabilities	75.08	218.91

Assets ($ Mln)

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Non-Current Assets	3.34	50.76
Current Assets	71.74	168.15
Total Assets	75.08	218.91
Total Debt*	2.52	58.09
Net Current Assets	58.73	107.58

Cashflow ($ Mln)

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Cash From Operating Activities	-60.35	-75.99
Cash Flow from Investing Activities	3.65	90.56
Cash from Financing Activities	1.44	-0.69
Net Cash Inflow / Outflow	39.42	--

Ratios

Profitability Ratios

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
ROCE (%)	-76.69	-3.70
ROE (%)	-78.26	-5.12
ROA (%)	-68.39	-2.91
EBIT Margin (%)	--	--
Net Margin (%)	--	-112.84
Cash Profit Margin (%)	--	--

Growth Ratios

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Revenue Growth (%)	--	13.46
EBIT Growth (%)	--	--
Net Profit Growth (%)	-121.70	78.31
EPS Growth (%)	-0.58	0.78
Book Value Growth (%)	--	--

Valuation Ratios

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Price / Earnings	-0.68	-0.60
Price / Book Value	0.81	0.05
Dividend Yield (%)	--	--
EV/EBITDA	0.17	10.01
Market Cap ($ Cr)	--	--

Solvency Ratios

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Debt to Equity	0.04	0.59
Short term debt to equity ratio	0.01	0.16
Current Ratio	5.52	2.78
Quick Ratio	12.75	2.72
Interest Coverage	-2,676.56	-33.86

Operating Efficiency Ratios

	Sio Gene Therapies (SIOX)	Orchard Therapeutics - ADR
Debtors to sales (%)	--	206.26
Asset Turnover	0.00	0.03
Receivable days	--	1,218.51
Inventory Days	-1,761.34	406.53
Payable days	1,314.95	1,450.64
Cash Conversion Cycle	--	174.40

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly